Onyx Pharmaceuticals Inc. (ONXX) announced that it has completed the acquisition of Proteolix Inc. Proteolix is a privately held biopharmaceutical company focused on discovering and developing therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.
For comments and feedback: editorial@rttnews.com